{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:08:18Z","timestamp":1785902898351,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA190216"],"award-info":[{"award-number":["T32CA190216"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA261605"],"award-info":[{"award-number":["P50CA261605"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32AR080630"],"award-info":[{"award-number":["T32AR080630"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR079379"],"award-info":[{"award-number":["R01AR079379"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009141","name":"Cancer League of Colorado","doi-asserted-by":"publisher","award":["AWD-242527-AB"],"award-info":[{"award-number":["AWD-242527-AB"]}],"id":[{"id":"10.13039\/100009141","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus"},{"DOI":"10.13039\/100013678","name":"Cancer Center, University of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Over 85% of children diagnosed with cancer now survive their disease, yet cancer and chemotherapy frequently associate with long-term health complications, including impaired musculoskeletal development. Despite high survival rates, there is limited research on how pediatric chemotherapy affects muscle and bone physiology. Vincristine, a vinca alkaloid chemotherapeutic, is widely used in pediatric oncology, but its systemic effects on the developing musculoskeletal system remain poorly understood. This study aimed to investigate the musculoskeletal consequences of vincristine in a pediatric mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Four-week-old male C57BL\/6J mice were administered vincristine (1.5\u00a0mg\/kg, intraperitoneally, twice weekly) or vehicle for five weeks. Body mass was monitored daily. At study endpoint (day 35), skeletal muscle mass and ex vivo extensor digitorum longus (EDL) muscle function were assessed. Trabecular and cortical bone microarchitecture were evaluated via micro-computed tomography (\u00b5CT). Molecular markers of muscle atrophy and mitochondrial function were analyzed using qPCR and western blotting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Vincristine-treated mice exhibited significantly reduced body mass (\u2212\u200929%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), skeletal muscle mass (quadriceps \u2212\u200939%, tibialis anterior \u2212\u200933%, gastrocnemius \u2212\u200925%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), and ex vivo EDL muscle force (\u2212\u200928%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Muscle fiber cross-sectional area was reduced (\u2212\u200922%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), and SDH staining revealed a shift from oxidative to glycolytic fibers. Molecular analyses showed increased phosphorylation of STAT3\n                      <jats:sup>Tyr705<\/jats:sup>\n                      (+\u2009267%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), no changes in the phosphorylation of AKT\n                      <jats:sup>Ser473<\/jats:sup>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), elevated expression of Atrogin-1 (+\u2009105%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and MUSA1 (+\u2009122%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), and decreased PGC-1\u03b1 expression (\u2212\u200944%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), overall suggesting enhanced protein degradation and mitochondrial dysfunction. The \u00b5CT analysis revealed significant trabecular bone loss (BV\/TV \u2212\u200984%, Tb.Th \u2212\u200918%, Tb.\n                      <jats:italic>N<\/jats:italic>\n                      \u2212\u200952%, Conn.D \u2212\u200989%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and cortical thinning (Ct.Th \u2212\u200921%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Plasma CTX-1 levels were significantly higher (+\u200951%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) in the vincristine-treated mice, indicating increased bone resorption.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vincristine impairs musculoskeletal development in pediatric mice, leading to muscle atrophy, muscle mitochondrial dysfunction, and bone loss. Altogether, these findings underscore the need for further research into the long-term systemic effects of this frequently prescribed pediatric anticancer agent and the development of interventions to preserve musculoskeletal health in childhood cancer survivors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15262-x","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:20:37Z","timestamp":1763464837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vincristine impairs musculoskeletal development in pediatric mice"],"prefix":"10.1186","volume":"25","author":[{"given":"Nicholas A.","family":"Jamnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb J.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia M.","family":"Weinzierl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"Novinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"2","key":"15262_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. Cancer J Clin. 2014;64(2):83\u2013103.","journal-title":"Cancer J Clin"},{"issue":"19","key":"15262_CR2","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1002\/cncr.33080","volume":"126","author":"DA Siegel","year":"2020","unstructured":"Siegel DA, Richardson LC, Henley SJ, Wilson RJ, Dowling NF, Weir HK, Tai EW, Buchanan Lunsford N. Pediatric cancer mortality and survival in the united States, 2001-2016. Cancer. 2020;126(19):4379\u201389.","journal-title":"Cancer"},{"key":"15262_CR3","unstructured":"Childhood Cancer Survivor Study. An Overview. https:\/\/www.cancer.gov\/types\/childhood-cancers\/ccss"},{"key":"15262_CR4","unstructured":"Race S. SEER cancer statistics review 1975\u20132014. 2017."},{"issue":"7","key":"15262_CR5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrclinonc.2012.88","volume":"9","author":"R Dantzer","year":"2012","unstructured":"Dantzer R, Meagher MW, Cleeland CS. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol. 2012;9(7):414\u201326.","journal-title":"Nat Rev Clin Oncol"},{"issue":"28","key":"15262_CR6","doi-asserted-by":"publisher","first-page":"43442","DOI":"10.18632\/oncotarget.9779","volume":"7","author":"R Barreto","year":"2016","unstructured":"Barreto R, Waning DL, Gao H, Liu Y, Zimmers TA, Bonetto A. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs. Oncotarget. 2016;7(28):43442.","journal-title":"Oncotarget"},{"issue":"5","key":"15262_CR7","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/jcsm.13035","volume":"13","author":"JR Huot","year":"2022","unstructured":"Huot JR, Pin F, Chatterjee R, Bonetto A. PGC1\u03b1 overexpression preserves muscle mass and function in cisplatin-induced cachexia. J Cachexia Sarcopenia Muscle. 2022;13(5):2480\u201391.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"15262_CR8","doi-asserted-by":"publisher","first-page":"zqae011","DOI":"10.1093\/function\/zqae011","volume":"5","author":"JR Huot","year":"2024","unstructured":"Huot JR, Livingston PD, Pin F, Thomas CR, Jamnick NA, Callaway CS, Bonetto A. Long-term musculoskeletal consequences of chemotherapy in pediatric mice. Function (Oxf). 2024;5(3):zqae011.","journal-title":"Function (Oxf)"},{"issue":"6","key":"15262_CR9","doi-asserted-by":"publisher","first-page":"R628","DOI":"10.1152\/ajpregu.00035.2025","volume":"328","author":"JR Huot","year":"2025","unstructured":"Huot JR, Jamnick NA, Pin F, Livingston PD, Callaway CS, Bonetto A. GL261 glioblastoma induces delayed body weight gain and stunted skeletal muscle growth in young mice. Am J Physiol Regul Integr Comp Physiol. 2025;328(6):R628\u201341.","journal-title":"Am J Physiol Regulatory Integr Comp Physiol"},{"issue":"2","key":"15262_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0163-7258(91)90081-V","volume":"51","author":"RH Himes","year":"1991","unstructured":"Himes RH. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Pharmacol Ther. 1991;51(2):257\u201367.","journal-title":"Pharmacol Ther"},{"issue":"8","key":"15262_CR11","first-page":"2212","volume":"51","author":"MA Jordan","year":"1991","unstructured":"Jordan MA, Thrower D, Wilson L. Mechanism of Inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 1991;51(8):2212\u201322.","journal-title":"Cancer Res"},{"issue":"11","key":"15262_CR12","doi-asserted-by":"publisher","first-page":"e31247","DOI":"10.1002\/pbc.31247","volume":"71","author":"JW Taub","year":"2024","unstructured":"Taub JW, Buck SA, Xavier AC, Edwards H, Matherly LH, Ge Y. The evolution and history of Vinca alkaloids: from the big Bang to the treatment of pediatric acute leukemia. Pediatr Blood Cancer. 2024;71(11):e31247.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"15262_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0014-4886(77)90163-7","volume":"55","author":"Y Wakayama","year":"1977","unstructured":"Wakayama Y, Sobue I. A tissue culture study of the toxic effect of vincristine on skeletal muscle. Exp Neurol. 1977;55(1):112\u201321.","journal-title":"Exp Neurol"},{"issue":"7","key":"15262_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to imageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135.","journal-title":"Nat Methods"},{"issue":"3","key":"15262_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/ijms22031486","volume":"22","author":"JR Huot","year":"2021","unstructured":"Huot JR, Pin F, Essex AL, Bonetto A. MC38 tumors induce musculoskeletal defects in colorectal cancer. Int J Mol Sci. 2021;22(3):1486.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"15262_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):1\u20137.","journal-title":"Sci Rep"},{"issue":"1","key":"15262_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M. Cellpose: a generalist algorithm for cellular segmentation. Nat Methods. 2021;18(1):100\u20136.","journal-title":"Nat Methods"},{"key":"15262_CR18","doi-asserted-by":"crossref","unstructured":"Hakim CH, Wasala NB, Duan D. Evaluation of muscle function of the extensor digitorum longus muscle ex vivo and tibialis anterior muscle in situ in mice. J Vis Exp. 2013;(72):e50183.","DOI":"10.3791\/50183"},{"issue":"1","key":"15262_CR19","doi-asserted-by":"publisher","first-page":"15049","DOI":"10.1038\/s41598-024-65313-9","volume":"14","author":"N Iguchi","year":"2024","unstructured":"Iguchi N, Teimouri A, Wilcox DT, Malykhina AP, Cost NG. Lower urinary dysfunction as a long-term effect of childhood vincristine treatment, with potential influences by sex and dose. Sci Rep. 2024;14(1):15049.","journal-title":"Sci Rep"},{"key":"15262_CR20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fendo.2019.00809","volume":"10","author":"AL Essex","year":"2019","unstructured":"Essex AL, Pin F, Huot JR, Bonewald LF, Plotkin LI, Bonetto A. Bisphosphonate treatment ameliorates chemotherapy-induced bone and muscle abnormalities in young mice. Front Endocrinol. 2019;10:809.","journal-title":"Front Endocrinol"},{"issue":"9","key":"15262_CR21","doi-asserted-by":"publisher","first-page":"e109030","DOI":"10.1371\/journal.pone.0109030","volume":"9","author":"P Hojman","year":"2014","unstructured":"Hojman P, Fjelbye J, Zerahn B, Christensen JF, Dethlefsen C, Lonkvist CK, Brandt C, Gissel H, Pedersen BK, Gehl J. Voluntary exercise prevents cisplatin-induced muscle wasting during chemotherapy in mice. PLoS ONE. 2014;9(9):e109030.","journal-title":"PLoS ONE"},{"issue":"1","key":"15262_CR22","doi-asserted-by":"publisher","first-page":"14470","DOI":"10.1038\/s41598-017-15040-1","volume":"7","author":"R Barreto","year":"2017","unstructured":"Barreto R, Kitase Y, Matsumoto T, Pin F, Colston KC, Couch KE, O\u2019Connell TM, Couch ME, Bonewald LF, Bonetto A. ACVR2B\/Fc counteracts chemotherapy-induced loss of muscle and bone mass. Sci Rep. 2017;7(1):14470.","journal-title":"Sci Rep"},{"issue":"3","key":"15262_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4162\/nrp.2019.13.3.214","volume":"13","author":"HR Yang","year":"2019","unstructured":"Yang HR, Choi HS. A prospective study on changes in body composition and fat percentage during the first year of cancer treatment in children. Nutr Res Pract. 2019;13(3):214\u201321.","journal-title":"Nutr Res Pract"},{"issue":"1\u20132","key":"15262_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/aac2.12027","volume":"2","author":"CG Goodenough","year":"2021","unstructured":"Goodenough CG, Partin RE, Ness KK. Skeletal muscle and childhood cancer: where are we now and where we go from here. Aging Cancer. 2021;2(1\u20132):13\u201335.","journal-title":"Aging Cancer"},{"issue":"12","key":"15262_CR25","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/mus.880121210","volume":"12","author":"F Di Gregorio","year":"1989","unstructured":"Di Gregorio F, Favaro G, Fiori MG. Functional evaluation of acute vincristine toxicity in rat skeletal muscle. Muscle Nerve. 1989;12(12):1017\u201323.","journal-title":"Muscle Nerve"},{"issue":"13","key":"15262_CR26","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.1016\/S0021-9258(20)82050-X","volume":"258","author":"A Hershko","year":"1983","unstructured":"Hershko A, Heller H, Elias S, Ciechanover A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem. 1983;258(13):8206\u201314.","journal-title":"J Biol Chem"},{"issue":"7","key":"15262_CR27","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1681\/ASN.2006010083","volume":"17","author":"SH Lecker","year":"2006","unstructured":"Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin\u2013proteasome pathway in normal and disease States. J Am Soc Nephrol. 2006;17(7):1807\u201319.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"15262_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/dmm.010389","volume":"6","author":"P Bonaldo","year":"2013","unstructured":"Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Models Mech. 2013;6(1):25\u201339.","journal-title":"Dis Models Mech"},{"key":"15262_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.freeradbiomed.2015.12.031","volume":"98","author":"O Rom","year":"2016","unstructured":"Rom O, Reznick AZ. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Free Radic Biol Med. 2016;98:218\u201330.","journal-title":"Free Radic Biol Med"},{"key":"15262_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mito.2023.07.003","volume":"72","author":"GB Kubat","year":"2023","unstructured":"Kubat GB, Bouhamida E, Ulger O, Turkel I, Pedriali G, Ramaccini D, Ekinci O, Ozerklig B, Atalay O, Patergnani S. Mitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies. Mitochondrion. 2023;72:33\u201358.","journal-title":"Mitochondrion"},{"issue":"6","key":"15262_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0031-6989(86)90147-5","volume":"18","author":"T Chantal","year":"1986","unstructured":"Chantal T, Nancy F, Claudette B, Gaston D, Aime C. Action of Vinca Alraloides on calcium movements through mitochondrial membrane. Pharmacol Res Commun. 1986;18(6):519\u201328.","journal-title":"Pharmacol Res Commun"},{"key":"15262_CR32","first-page":"S63","volume":"24","author":"B Islam","year":"2019","unstructured":"Islam B, Lustberg M, Staff NP, Kolb N, Alberti P, Argyriou AA. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: from pathogenesis to treatment. J Peripheral Nerv Syst. 2019;24:S63\u201373.","journal-title":"J Peripheral Nerv Syst"},{"key":"15262_CR33","doi-asserted-by":"crossref","unstructured":"Seibel MJ, Meier C. Biochemical markers of bone turnover\u2013basic biochemistry and variability. In: Adler, R. (eds) Osteoporosis. Contemporary Endocrinology. Humana Press. 2010;97\u2013130.","DOI":"10.1007\/978-1-59745-459-9_5"},{"key":"15262_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-017-0097-4","volume":"5","author":"T-R Kuo","year":"2017","unstructured":"Kuo T-R, Chen C-H. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 2017;5:1\u20139.","journal-title":"Biomark Res"},{"key":"15262_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08518-9","volume":"21","author":"H Zwickl","year":"2021","unstructured":"Zwickl H, Zwickl-Traxler E, Haushofer A, Seier J, Podar K, Weber M, Hackner K, Jacobi N, Pecherstorfer M, Vallet S. Effect of cachexia on bone turnover in cancer patients: a case-control study. BMC Cancer. 2021;21:1\u20139.","journal-title":"BMC Cancer"},{"issue":"25","key":"15262_CR36","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1200\/JCO.18.01917","volume":"37","author":"JE van Atteveld","year":"2019","unstructured":"van Atteveld JE, Pluijm SM, Ness KK, Hudson MM, Chemaitilly W, Kaste SC, Robison LL, Neggers SJ, Yasui Y, van den Heuvel-Eibrink MM. Prediction of low and very low bone mineral density among adult survivors of childhood cancer. J Clin Oncol. 2019;37(25):2217\u201325.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15262-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:04:35Z","timestamp":1763510675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15262-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15262"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15262-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were conducted with the approval of the Institutional Animal Care and Use Committee at the University of Colorado Anschutz Medical Campus, Aurora, CO and were in compliance with the National Institutes of Health Guidelines for Use and care of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1782"}}